Cargando…
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270501/ https://www.ncbi.nlm.nih.gov/pubmed/32209313 http://dx.doi.org/10.1016/j.oraloncology.2020.104659 |
_version_ | 1783541909473460224 |
---|---|
author | Bennardo, Francesco Buffone, Caterina Giudice, Amerigo |
author_facet | Bennardo, Francesco Buffone, Caterina Giudice, Amerigo |
author_sort | Bennardo, Francesco |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7270501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72705012020-06-05 New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws Bennardo, Francesco Buffone, Caterina Giudice, Amerigo Oral Oncol Article Elsevier Ltd. 2020-07 2020-03-21 /pmc/articles/PMC7270501/ /pubmed/32209313 http://dx.doi.org/10.1016/j.oraloncology.2020.104659 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bennardo, Francesco Buffone, Caterina Giudice, Amerigo New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws |
title | New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws |
title_full | New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws |
title_fullStr | New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws |
title_full_unstemmed | New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws |
title_short | New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws |
title_sort | new therapeutic opportunities for covid-19 patients with tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270501/ https://www.ncbi.nlm.nih.gov/pubmed/32209313 http://dx.doi.org/10.1016/j.oraloncology.2020.104659 |
work_keys_str_mv | AT bennardofrancesco newtherapeuticopportunitiesforcovid19patientswithtocilizumabpossiblecorrelationofinterleukin6receptorinhibitorswithosteonecrosisofthejaws AT buffonecaterina newtherapeuticopportunitiesforcovid19patientswithtocilizumabpossiblecorrelationofinterleukin6receptorinhibitorswithosteonecrosisofthejaws AT giudiceamerigo newtherapeuticopportunitiesforcovid19patientswithtocilizumabpossiblecorrelationofinterleukin6receptorinhibitorswithosteonecrosisofthejaws |